» Articles » PMID: 16732316

Radiation-enhanced Hepatocellular Carcinoma Cell Invasion with MMP-9 Expression Through PI3K/Akt/NF-kappaB Signal Transduction Pathway

Overview
Journal Oncogene
Date 2006 May 30
PMID 16732316
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

This study is to investigate the molecular mechanism of radiation-enhanced cell invasiveness of hepatocellular carcinoma (HCC) correlating with clinical patients undergoing radiotherapy and subsequently developing metastasis. Three HCC cell lines (HepG2, Hep3B and Huh7) and normal hepatocyte cell line (CL-48) were irradiated with different doses. The effect of radiation on cell invasiveness was determined using the Boyden chamber assay. Radiation-enhanced invasion capability was evident in HCC cells but not in normal hepatocytes. Invasion was observed in gelatin-coated but not fibronectin-coated or type I collagen-coated membranes. Radiation upregulated matrix metalloproteinase-9 (MMP-9) mRNA level, MMP-9 protein level and MMP-9 activity. MMP-9 antisense oligonucleotides inhibited radiation-induced MMP-9 expression and thereby significantly inhibited radiation-induced HCC invasion. Furthermore, phosphatidylinositol 3-kinase (PI3K)/Akt chemical inhibitors LY294002 and wortmannin suppressed radiation-induced MMP-9 mRNA expression. Transient transfection with dominant-negative Akt plasmid also showed that the PI3K/Akt-signaling pathway was involved in this radiation-induced MMP-9 expression. Moreover, nuclear factor-kappaB (NF-kappaB) decoy oligodeoxynucleotide suppressed radiation enhanced MMP-9 promoter activity completely. PI3K/Akt chemical inhibitors inhibited radiation-induced NF-kappaB-driven luciferase promoter activity. Taken together, our results indicated that sublethal dose of radiation could enhance HCC cell invasiveness by MMP-9 expression through the PI3K/Akt/NF-kappaB signal transduction pathway.

Citing Articles

Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers.

Zhao D, Mo Y, Neganova M, Aleksandrova Y, Tse E, Chubarev V Front Cell Dev Biol. 2023; 11:1266537.

PMID: 37849740 PMC: 10577389. DOI: 10.3389/fcell.2023.1266537.


Local Liver Irradiation Concurrently Versus Sequentially with Cabozantinib on the Pharmacokinetics and Biodistribution in Rats.

Huang Y, Hsieh P, Wang L, Tsai T, Chen Y, Hsieh C Int J Mol Sci. 2023; 24(6).

PMID: 36982920 PMC: 10056485. DOI: 10.3390/ijms24065849.


Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms.

Maugeri A, Calderaro A, Patane G, Navarra M, Barreca D, Cirmi S Int J Mol Sci. 2023; 24(3).

PMID: 36769274 PMC: 9918234. DOI: 10.3390/ijms24032952.


The linker of nucleoskeleton and cytoskeleton complex is required for X-ray-induced epithelial-mesenchymal transition.

Imaizumi H, Minami K, Hieda M, Narihiro N, Koizumi M J Radiat Res. 2023; 64(2):358-368.

PMID: 36694940 PMC: 10036107. DOI: 10.1093/jrr/rrac104.


Tepotinib suppresses proliferation, invasion, migration, and promotes apoptosis of melanoma cells via inhibiting MET and PI3K/AKT signaling pathways.

Jing G, Yu F, Xue H Oncol Lett. 2022; 23(6):170.

PMID: 35497936 PMC: 9019857. DOI: 10.3892/ol.2022.13290.